nefopam and cyclic gmp

nefopam has been researched along with cyclic gmp in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biella, G; Brini, AT; Díaz-Trelles, R; Fernández-Sánchez, MT; Groppetti, A; Manfredi, B; Novelli, A; Sotgiu, ML	1
Díaz-Trelles, R; Fernández-Sánchez, MT; Groppetti, A; Novelli, A	1

Other Studies

2 other study(ies) available for nefopam and cyclic gmp

Article	Year
Novel effect of nefopam preventing cGMP increase, oxygen radical formation and neuronal death induced by veratridine. Neuropharmacology, 2001, Volume: 41, Issue:8 Topics: Analgesics, Non-Narcotic; Animals; Cell Death; Cells, Cultured; Cerebellum; Cyclic GMP; Dose-Response Relationship, Drug; Nefopam; Neurons; Rats; Reactive Oxygen Species; Veratridine	2001
Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels. Amino acids, 2005, Volume: 28, Issue:2 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Analgesics, Non-Narcotic; Animals; Calcium; Calcium Channel Agonists; Calcium Channels; Calcium Signaling; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Kainic Acid; N-Methylaspartate; Nefopam; Neuromuscular Depolarizing Agents; Neurons; Neurotoxins; Rats; Receptors, N-Methyl-D-Aspartate	2005

Article

Year

Novel effect of nefopam preventing cGMP increase, oxygen radical formation and neuronal death induced by veratridine.

Neuropharmacology, 2001, Volume: 41, Issue:8

Topics: Analgesics, Non-Narcotic; Animals; Cell Death; Cells, Cultured; Cerebellum; Cyclic GMP; Dose-Response Relationship, Drug; Nefopam; Neurons; Rats; Reactive Oxygen Species; Veratridine

2001

Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels.

Amino acids, 2005, Volume: 28, Issue:2

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Analgesics, Non-Narcotic; Animals; Calcium; Calcium Channel Agonists; Calcium Channels; Calcium Signaling; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Kainic Acid; N-Methylaspartate; Nefopam; Neuromuscular Depolarizing Agents; Neurons; Neurotoxins; Rats; Receptors, N-Methyl-D-Aspartate

2005